Loading company…
Medo develops AI software for ultrasound imaging and medical workflows.
Medo develops AI-based ultrasound imaging software intended to improve diagnostic capabilities and efficiency in medical practices. Founded in 2017, the company is based in Edmonton, Canada. Exo Imaging acquired it on July 26, 2022, to integrate its AI algorithms with Exo's hardware and workflow technologies. Its Series A was funded by Great Noble International and elev8.vc.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in